深圳市人民医院Shenzhen People's Hospital

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Shenzhen 深圳市

   已发表研究

   • A case-control study of dietary patterns and lifestyle factors affecting colorectal cancer in Hunan province, South China. Medicine, 2026
   • R-loops in colorectal cancer: mechanisms, mapping strategies, and therapeutic opportunities. Molecular biology reports, 2026

   另有 2 项已发表研究

   PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。

2. Breast cancer

   Shenzhen 深圳市

   已发表研究

   • Pharmacologic management of postoperative sleep disturbance in breast cancer. Frontiers in pharmacology, 2026
   • Development and Validation of an Interpretable Model Integrating Radiomics and Clinical Data for Predicting 70-gene Signature Risk in Breast Cancer: A Multicenter Study. Academic radiology, 2026

   另有 2 项已发表研究

   PubMed 收录了 4 篇关于该疾病、并提及这家医院的论文。

3. Liver cancer

   Shenzhen 深圳市

   已发表研究

   • The landscape mapping of single-cell sequencing in the research progression and hotspots of liver cancer based on systematical analysis. Medicine, 2026
   • Capillarisenol C, a novel bisphenol from Artemisia capillaris, induces ER stress-mediated cytotoxic autophagy in liver cancer cells. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

4. Esophageal cancer

   Shenzhen 深圳市

   已发表研究

   • Network pharmacology-guided identification and validation of ganoderic acids A and D from Ganoderma lucidum against esophageal squamous cell carcinoma. Biochemical and biophysical research communications, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。